Goldman Sachs Maintains Buy on Grupo Cibest, Raises Price Target to $110
Goldman Sachs analyst Tito Labarta maintains Grupo Cibest (NYSE:CIB) with a Buy and raises the price target from $98 to $110.
Read original at benzingaStocks · News reference
JP Morgan Upgrades Grupo Cibest to Overweight, Raises Price Target to $110
JP Morgan analyst Yuri Fernandes upgrades Grupo Cibest (NYSE:CIB) from Neutral to Overweight and raises the price target from $70 to $110.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 11, 2026, 12:09 PM
- Checked
- Aug 11, 2026, 12:09 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Grupo Cibest shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $70 to $110.
Read original at benzingaThis Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts upgraded Grupo Cibest, Lufax, Honeywell, and Gossamer Bio. JBS also received an upgrade. See what analysts think.
Read original at benzinga